Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 10:40:02 2024-05-22 pm EDT 		5-day change 1st Jan Change
47.65 HKD +0.74% Intraday chart for Akeso, Inc. -4.23% +2.59%
Apr. 24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
Apr. 24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI
Chart Akeso, Inc.
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
  5. Static Chart